NanoEntek, Inc. (KOSDAQ:039860)

South Korea · Delayed Price · Currency is KRW

3,810.00

+170.00 (4.67%)

At close: Aug 24, 2026

6.87% (1Y)

Market Cap	145.13B +26.8%
Revenue (ttm)	40.66B +27.7%
Net Income	2.65B -21.9%
EPS	75.61 -30.4%
Shares Out	38.09M
PE Ratio	50.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	433,660
Open	3,640.00
Previous Close	3,640.00
Day's Range	3,640.00 - 4,045.00
52-Week Range	3,015.00 - 9,390.00
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About NanoEntek

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic... [Read more]

Industry Laboratory Analytical Instruments

Founded 1987

Employees 97

Stock Exchange KOSDAQ

Ticker Symbol 039860

Full Company Profile

Financial Performance

In 2025, NanoEntek's revenue was 38.13 billion, an increase of 25.16% compared to the previous year's 30.46 billion. Earnings were 1.58 billion, a decrease of -55.93%.

Financial Statements